908 Devices, a pioneer of purpose-built handheld and desktop devices for chemical and biomolecular analysis, on January 7th announced that GlaxoSmithKline has purchased an additional REBEL™ cell culture media analyzer. GSK will now have a total of five REBEL analyzers being used by its biologics and vaccine process development teams.
Read more about this news here.
